ONTARIO, Calif. -- The "Foundations of Infection Control" program, sponsored by the California APIC Coordinating Council, will be held Sept. 19-23, 2004 at the Ontario Airport Marriott.
This three-part program is for new or intermediate infection control practitioners and/or public health professionals in acute, long-term care, correctional facilities, home health, psychiatric settings, ambulatory care or public health facilities/clinics seeking an introductory course to help them understand the components of an infection control program. Each part of the program may be taken alone or in combination. The full week is recommended for beginners.
The three-and-a-half day program focuses on the patient, the environment and administrative/educational issues. This will help define the components required in a comprehensive infection control program. In addition, there will be a vendor fair and reception.
"Surviving the Survey Process in the Infection Control Arena" is a half-day program on Wednesday addressing regulatory and Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) guidelines. "Statistics, Use of Data, PI & Project Management" will be held on Thursday.
All sessions include hands-on exercises, small group sessions and an opportunity for informal interaction with group leaders and topic experts.
Nursing and clinical laboratory CE units will be available. Visit www.cacc.net for costs, hotel availability and registration information.
To receive a brochure, receive vendor display information or inquire about program details, send an email to Harriett Pitt at Hpitt@memorialcare.org or call (526) 933-0389. An alternate contact is Mary Mendelsohn at mary.mendelsohn@huntingtonhospital.com or call (626) 397-5138
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.